Healdsburg Hospital
1375 University Ave, Healdsburg, CA · Providence · · NPI 1295342012
Published prices by procedure
Cash price is what you pay without insurance. The negotiated range spans the lowest to highest rate this hospital agreed with insurers.
| Procedure | Cash price | Gross charge | Negotiated range | Payers |
|---|---|---|---|---|
| Inj efgart-alfa 2mg hya-qvfc HCPCS J9334 | not published | not published | $32.56 – $106.22 | 4 |
| Inj eflapegrastim-xnst 0.1mg HCPCS J1449 | not published | not published | $34.77 – $115.68 | 4 |
| Inj., emapalumab-lzsg, 1 mg HCPCS J9210 | not published | not published | $370.42 – $1,145.88 | 4 |
| Inj., emicizumab-kxwh 0.5 mg HCPCS J7170 | not published | not published | $55.64 – $168.24 | 4 |
| Inj epidural sgl cerv-thor without img CPT 62320 | $792.03 | $1,553.00 | $951.06 – $3,982.87 | 3 |
| Inj epidural sgl lumb-sacral without img CPT 62322 | $1,170.45 | $2,295.00 | $1,191.69 – $3,982.87 | 3 |
| Inj, epinephrine (belcher) HCPCS J0173 | not published | not published | $1.11 – $4.76 | 3 |
| Inj., eravacycline, 1 mg HCPCS J0122 | not published | not published | $1.19 – $3.33 | 4 |
| Inj, erzofri, 1 mg HCPCS J2428 | not published | not published | $14.49 – $33.16 | 3 |
| Inj, etelcalcetide, 0.1 mg HCPCS J0606 | not published | not published | $2.36 – $11.00 | 4 |
| Inj, eteplirsen, 10 mg HCPCS J1428 | not published | not published | $163.20 – $543.00 | 4 |
| Inj, evinacumab-dgnb, 5mg HCPCS J1305 | not published | not published | $186.45 – $530.24 | 4 |
| Inj., evomela, 1 mg HCPCS J9246 | not published | not published | $19.43 – $135.73 | 4 |
| Inj, exagamglogene autotem HCPCS J3392 | not published | not published | $2,244,000.00 – $2,332,000.00 | 2 |
| Inj, factor x, (human), 1iu HCPCS J7175 | not published | not published | $9.95 – $26.17 | 4 |
| Inj, faricimab-svoa, 0.1mg HCPCS J2777 | not published | not published | $32.87 – $123.82 | 4 |
| Inj fe-based mr contrast,1ml HCPCS Q9953 | not published | not published | $91.27 – $91.27 | 1 |
| Inj. fe derisomaltose 10 mg HCPCS J1437 | not published | not published | $21.93 – $83.60 | 4 |
| Inj fensolvi 0.25 mg HCPCS J1951 | not published | not published | $140.71 – $425.56 | 4 |
| Inj ferric pyrophosphate cit HCPCS J1443 | not published | not published | $0.03 – $0.09 | 3 |
| Inj., fibryga, 1 mg HCPCS J7177 | not published | not published | $1.12 – $3.74 | 4 |
| Inj fluphenazine hcl 1.25 mg HCPCS J2679 | not published | not published | $9.79 – $32.55 | 3 |
| Inj, focinvez, 1mg HCPCS J1434 | not published | not published | $2.55 – $10.34 | 4 |
| Inj follitropin alfa 75 iu HCPCS S0126 | not published | not published | $246.34 – $481.08 | 3 |
| Inj follitropin beta 75 iu HCPCS S0128 | not published | not published | $221.85 – $553.40 | 3 |
| Inj for ext venography CPT 36005 | $860.88 | $1,688.00 | $3,982.87 – $3,982.87 | 1 |
| Inj for mammo ductogram CPT 19030 | not published | not published | $3,982.87 – $3,982.87 | 1 |
| Inj, fosaprepitant (teva) HCPCS J1456 | not published | not published | $0.04 – $6.82 | 4 |
| Inj fosnetupitant, palonoset HCPCS J1454 | not published | not published | $524.18 – $1,730.60 | 4 |
| Inj., fremanezumab-vfrm 1 mg HCPCS J3031 | not published | not published | $3.43 – $9.55 | 3 |
| Inj, fulvestrant (fresenius) HCPCS J9394 | not published | not published | $24.52 – $169.56 | 4 |
| Inj, fulvestrant (teva) HCPCS J9393 | not published | not published | $20.40 – $67.96 | 4 |
| Inj, gadopiclenol, 1 ml HCPCS A9573 | not published | not published | $37.48 – $37.48 | 1 |
| Inj, ganciclovir (exela) HCPCS J1574 | not published | not published | $51.00 – $169.56 | 3 |
| Inj ganirelix acetat 250 mcg HCPCS S0132 | not published | not published | $185.41 – $622.48 | 3 |
| Inj gemcitabine hcl (accord) HCPCS J9196 | not published | not published | $11.31 – $37.61 | 3 |
| Inj givosiran 0.5 mg HCPCS J0223 | not published | not published | $115.00 – $350.09 | 4 |
| Inj glofitamab gxbm, 2.5 mg HCPCS J9286 | not published | not published | $2,684.01 – $8,668.60 | 4 |
| Inj glycopyrrolate fres kabi HCPCS J1598 | not published | not published | $2.60 – $8.58 | 3 |
| Inj glycopyrrolate, glyrx-pf HCPCS J1597 | not published | not published | $1.63 – $5.50 | 3 |
| Inj golodirsen 10 mg HCPCS J1429 | not published | not published | $163.20 – $542.90 | 3 |
| Inj, granisetron, xr, 0.1 mg HCPCS J1627 | not published | not published | $3.88 – $17.15 | 4 |
| Inj., guselkumab, 1 mg HCPCS J1628 | not published | not published | $67.81 – $344.62 | 4 |
| Inj., haegarda 10 units HCPCS J0599 | not published | not published | $12.34 – $31.89 | 3 |
| Inj, hemgenix, per tx dose HCPCS J1411 | not published | not published | $3,570,000.00 – $3,691,450.00 | 2 |
| Inj heparin, pfizer, 1000u HCPCS J1643 | not published | not published | $1.10 – $7.04 | 3 |
| Inj. herceptin hylecta, 10mg HCPCS J9356 | not published | not published | $59.91 – $264.38 | 4 |
| Inj, hercessi, 10 mg HCPCS Q5146 | not published | not published | $37.86 – $299.32 | 3 |
| Inj herzuma 10 mg HCPCS Q5113 | not published | not published | $56.02 – $317.26 | 4 |
| Inj hrt cath w/s&i nonsel p-art angrp CPT 93568 | not published | not published | $7,151.31 – $7,151.31 | 1 |
| Inj hrt cath w/s&i sel hrt ang CPT 93563 | not published | not published | $7,151.31 – $7,151.31 | 1 |
| Inj hrt cath w/s&i sel hrt art CPT 93564 | not published | not published | $7,151.31 – $7,151.31 | 1 |
| Inj hrt cath w/s&i sel left vent CPT 93565 | not published | not published | $7,151.31 – $7,151.31 | 1 |
| Inj hrt cath w/s&i sel right vent CPT 93566 | not published | not published | $7,151.31 – $7,151.31 | 1 |
| Inj human fibrinogen con nos HCPCS J7178 | not published | not published | $1.52 – $3.08 | 4 |
| Inj hydroxocobalamin IV 25mg HCPCS J3424 | not published | not published | $5.09 – $16.49 | 4 |
| Inj hydroxyprogst capoat nos HCPCS J1729 | not published | not published | $13.91 – $52.34 | 3 |
| Inj., ibalizumab-uiyk, 10 mg HCPCS J1746 | not published | not published | $77.68 – $192.66 | 4 |
| Inj, idacio, 1 mg HCPCS Q5144 | not published | not published | $22.92 – $76.31 | 2 |
| Inj imip 4 cilas 4 releb 2mg HCPCS J0742 | not published | not published | $2.58 – $7.51 | 3 |
| Inj, imm glob bivigam, 500mg HCPCS J1556 | not published | not published | $76.77 – $206.51 | 4 |
| Inj, immphentiv, 20 mcg HCPCS J2373 | not published | not published | $0.20 – $0.66 | 3 |
| Inj. inebilizumab-cdon, 1 mg HCPCS J1823 | not published | not published | $476.84 – $1,481.64 | 4 |
| Inj/inf neurolyt sbst spinal canal lesion 62282 CPT 62282 | not published | not published | $1,191.69 – $3,982.87 | 3 |
| Inj. infugem, 100 mg HCPCS J9198 | not published | not published | $38.76 – $128.94 | 3 |
| Inj. insulin (fiasp) HCPCS J1812 | not published | not published | $1.48 – $4.84 | 3 |
| Inj intralesional <= 7 lsn(s) CPT 11900 | $221.85 | $435.00 | $270.32 – $3,982.87 | 3 |
| Inj intralesional > 7 lsns CPT 11901 | not published | not published | $270.32 – $3,982.87 | 3 |
| Inj, invega hafyera/trinza HCPCS J2427 | not published | not published | $12.95 – $41.35 | 4 |
| Inj ivig privigen 500 mg HCPCS J1459 | not published | not published | $49.53 – $152.85 | 4 |
| Inj, ixinity, 1 i.u HCPCS J7213 | not published | not published | $1.97 – $6.82 | 4 |
| Inj. jivi 1 iu HCPCS J7208 | not published | not published | $2.66 – $7.82 | 4 |
| Inj, kovaltry, 1 i.u HCPCS J7211 | not published | not published | $1.56 – $5.72 | 4 |
| Inj labetalol hcl hikma, 5mg HCPCS J1921 | not published | not published | $2.76 – $10.12 | 3 |
| Inj., lanadelumab-flyo, 1 mg HCPCS J0593 | not published | not published | $86.85 – $257.12 | 4 |
| Inj, lanreotide, (cipla) 1mg HCPCS J1932 | not published | not published | $32.19 – $251.38 | 4 |
| Inj, lecanemab-irmb, 1 mg HCPCS J0174 | not published | not published | $1.32 – $4.40 | 4 |
| Inj lefamulin 1 mg HCPCS J0691 | not published | not published | $0.70 – $2.32 | 3 |
| Inj, lenacapavir, 1 mg HCPCS J1961 | not published | not published | $21.45 – $71.48 | 4 |
| Inj levocarnitine per 1 gm HCPCS J1955 | not published | not published | $36.38 – $120.74 | 3 |
| Inj levoleucovorin nos 0.5mg HCPCS J0641 | not published | not published | $0.08 – $4.40 | 3 |
| Inj, levothyroxine, freskabi HCPCS J0651 | $250.28 | $490.75 | $6.96 – $37.61 | 4 |
| Inj, levothyroxine, hikma HCPCS J0652 | not published | not published | $7.64 – $25.51 | 3 |
| Inj, lidocaine w epinephrine HCPCS J2004 | $84.15 | $165.00 | $0.01 – $0.22 | 3 |
| Inj, linezolid (hospira) HCPCS J2021 | not published | not published | $16.54 – $71.70 | 3 |
| Inj, lovotibeglogene autotem HCPCS J3394 | not published | not published | $3,162,000.00 – $3,245,381.39 | 2 |
| Inj. lumasiran, 0.5 mg HCPCS J0224 | not published | not published | $324.34 – $987.47 | 4 |
| Inj., lumoxiti, 0.01 mg HCPCS J9313 | not published | not published | $22.51 – $74.87 | 4 |
| Inj luxturna 1 billion vec g HCPCS J3398 | not published | not published | $3,070.09 – $9,613.85 | 4 |
| Inj lwr xtr fscl pln blk uni w/wo image CPT 64473 | not published | not published | $721.00 – $721.00 | 1 |
| Inj marstacim-hncq, 0.5 mg HCPCS J7172 | not published | not published | $50.19 – $52.02 | 2 |
| Inj. meloxicam 1 mg HCPCS J1738 | not published | not published | $3.20 – $10.62 | 3 |
| Inj melpha hydroch nos 50 mg HCPCS J9245 | not published | not published | $120.67 – $1,302.62 | 4 |
| Inj, melphalan (apotex) 1 mg HCPCS J9249 | not published | not published | $62.33 – $64.78 | 2 |
| Inj, melphalan flufenami 1mg HCPCS J9247 | not published | not published | $484.50 – $1,611.84 | 2 |
| Inj melphalan (hepzato) 1 mg HCPCS J9248 | not published | not published | $765.00 – $2,477.03 | 4 |
| Inj menotropins 75 iu HCPCS S0122 | not published | not published | $257.51 – $483.56 | 3 |
| Inj mepivacaine hcl/10 ml HCPCS J0670 | not published | not published | $3.19 – $47.28 | 3 |
| Inj, meropenem (b. braun) HCPCS J2184 | not published | not published | $3.62 – $12.10 | 3 |
| Inj., meropenem, vaborbactam HCPCS J2186 | not published | not published | $2.17 – $5.50 | 4 |
A missing value means the hospital did not publish that price — it never means the price is zero. Real bills can add facility fees, supplies and professional fees; see our methodology.